Printer Friendly

COMPANY INFORMATION
Manitex Capital Inc. 16667 boul Hymus Montréal, QC H9H 4R9 Tel: (514) 693-8830 Fax: (514) 694-0443 Contact Name Helen Saviuk Industry Other Diversified Financial Services		Key Executives Steven Saviuk, CEO Helen Saviuk, acting CFO Invests in and provides strategic advice to emerging technology companies. Holds 63.75% interest in Hywood Pharmachem Inc., a bulk chemical distributor to pharmaceutical and health food manufacturers in Canada and the U.S. Also invests in the life science industry and, through affiliate Valeo Pharma Inc., develops pharmaceutical products and markets over-the-counter and prescription products.
FP ADVISOR COVERAGE Manitex Capital Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Other Diversified Financial Services Company Name Revenue ($000s)  Central Fund of Canada Limited 859,091 Newport Partners Income Fund 669,730 Davis + Henderson Income Fund 367,231 Clarke Inc. 250,145 TerraVest Income Fund 241,711 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF JAN 13/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/MNX $0.13 $0.20 $0.11 n.a. n.a. n.a. 1.35 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 80 n.a. $-0.04 July 31/09 22.73% -13.69% 17.61% $1,607
ANNUAL FINANCIALS Periods ended: 12m Oct. 31/08 12m Oct. 31/07 12m Oct. 31/06 $000s $000s $000s Operating revenue 18,942 19,743 21,712 Net income 1,027 488 1,352 Total assets 13,437 13,672 9,385 $ $ $ Earnings per share* 0.08 0.04 0.11 % % % Return on equity 16.48 8.30 33.00   * Common
TRAILING 12-MONTH VALUES Periods ended: July 31/09 July 31/08 $000s $000s Operating revenue 17,743 20,900 Net income (485) 1,077 $ $ Earnings per share (0.04) 0.09

COMPANY NEWS

Results for 'Manitex Capital Inc.' from past 30 days: No hits. (Links are to articles.)